z-logo
open-access-imgOpen Access
Association of Prediabetes and Type 2 Diabetes With Cognitive Function After Stroke
Author(s) -
Jessica Lo,
John D. Crawford,
Katherine Samaras,
David W. Desmond,
Sebastian Köhler,
Julie Staals,
Frans R.J. Verhey,
HeeJoon Bae,
KeonJoo Lee,
Beom Joon Kim,
Régis Bordet,
Charlotte Cordonnier,
Thibaut Dondaine,
AnneMarie Mendyk,
ByungChul Lee,
KyungHo Yu,
JaeSung Lim,
Nagaendran Kandiah,
Russell J. Chander,
Chathuri Yatawara,
Darren M. Lipnicki,
Perminder S. Sachdev
Publication year - 2020
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.119.028428
Subject(s) - medicine , prediabetes , dementia , diabetes mellitus , stroke (engine) , type 2 diabetes , type 2 diabetes mellitus , population , impaired fasting glucose , cognition , cognitive decline , impaired glucose tolerance , endocrinology , psychiatry , mechanical engineering , disease , environmental health , engineering
Background and Purpose— Type 2 diabetes mellitus (T2D) is associated with cognitive impairment and an increased risk of dementia, but the association between prediabetes and cognitive impairment is less clear, particularly in a setting of major cerebrovascular events. This article examines the impact of impaired fasting glucose and T2D on cognitive performance in a stroke population. Methods— Seven international observational studies from the STROKOG (Stroke and Cognition) consortium (n=1601; mean age, 66.0 years; 70% Asian, 26% white, and 2.6% African American) were included. Fasting glucose level (FGL) during hospitalization was used to define 3 groups, T2D (FGL ≥7.0 mmol/L), impaired fasting glucose (FGL 6.1–6.9 mmol/L), and normal (FGL <6.1 mmol/L), and a history of diabetes mellitus and the use of a diabetes mellitus medication were also used to support a diagnosis of T2D. Domain and global cognitionZ scores were derived from standardized neuropsychological test scores. The cross-sectional association between glucose status and cognitive performance at 3 to 6 months poststroke was examined using linear mixed models, adjusting for age, sex, education, stroke type, ethnicity, and vascular risk factors.Results— Patients with T2D had significantly poorer performance in global cognition (SD, −0.59 [95% CI, −0.82 to −0.36];P <0.001) and in all domains compared with patients with normal FGL. There was no significant difference between impaired fasting glucose patients and those with normal FGL in global cognition (SD, −0.10 [95% CI, −0.45 to 0.24];P =0.55) or in any cognitive domain.Conclusions— Diabetes mellitus, but not prediabetes, is associated with poorer cognitive performance in patients 3 to 6 months after stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom